ORCID Profile
0000-0002-3635-1123
Current Organisations
Commonwealth Scientific and Industrial Research Organisation
,
CSIRO
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Publisher: Springer Science and Business Media LLC
Date: 18-05-2021
Publisher: Elsevier BV
Date: 08-2016
Publisher: Springer Science and Business Media LLC
Date: 04-10-2014
DOI: 10.1007/S10534-014-9798-4
Abstract: Lactoferrin (Lf), present in colostrum and milk is a member of the transferrin family of iron-binding glyco-proteins, with stronger binding capacity to ferric iron than hemoglobin, myoglobin or transferrin. Unlike hemoglobin and myoglobin, iron-bound Lf is reasonably stable to gastric and duodenal digestive conditions. Unlike ferrous iron, ferric iron is not directly reactive with oxygen supporting the capacity of Lf capture of heme iron to suppress reactive oxygen species (ROS) production. We therefore hypothesized that bovine Lf could capture and thereby terminate the cycle of ROS production by heme iron. The transfer of heme iron from either intact or digested forms of hemoglobin and myoglobin and from intact ferritin was demonstrated by in vitro methods, monitoring Fe-saturation status of Lf by changes in absorptivity at 465 nm. The results are discussed in the context of new proposed opportunities for orally administered Lf to regulate oxidative damage associated with heme iron. In addition to potentially suppressing oxidative heme-iron-mediated tissue damage in the lumen, Lf is expected to also reverse the overload of ferritin-bound iron, that accompanies chronic inflammation and aging. These new proposed uses of Lf are additional to known host defense functions that include anti-microbial, anti-viral properties, immune and cancer cell growth regulation. The findings and interpretations presented require clinical substantiation and may support important additional protective and therapeutic uses for Lf in the future.
Publisher: Elsevier BV
Date: 04-2011
Publisher: Royal Society of Chemistry (RSC)
Date: 2013
DOI: 10.1039/C3FO60197H
Abstract: Spray dried emulsions are effective for carrying and stabilising combinations of fish oil and tributyrin, fish oil and resveratrol, or fish oil, tributyrin and resveratrol in one formulation. The encapsulation efficiencies were >99% for all three bioactives when a heated mixture of sodium caseinate: glucose: dried glucose syrup matrix (Encapsulant matrix 1) was used. When a heated sodium caseinate: glucose: processed starch matrix (Encapsulant matrix 2) was used, the encapsulation efficiencies were 90-92% for tributyrin and approximately 98% for resveratrol for all formulations but 79-91% for tuna oil where the efficiency was more formulation dependent. There was 84-86% remaining EPA, 85-87% remaining DHA, 85% remaining tributyrin and 94-96% remaining resveratrol after 18 months at 25 °C storage of the spray dried emulsions using Encapsulant matrix 1 across all formulations. In comparison, there was 83-87% remaining EPA and 84-89% remaining DHA, 80-82% remaining tributyrin, and 81-100% remaining resveratrol across all formulations with Encapsulant matrix 2. In vitro studies showed that on sequential exposure to simulated gastric and intestinal fluids, <5% tuna oil was found as triglycerides, but all the tributyrin had been lipolysed. The presence of diglycerides, monoglycerides and free fatty acids in the in vitro digests suggested that lipolysis of tuna oil had occurred. The type of matrix used for encapsulating the bioactives had little effect on the lipolysis of the oils but affected the amount of solvent extractable resveratrol. The ability of delivering mixtures of bioactives within one formulation was demonstrated.
Publisher: Wiley
Date: 11-2010
DOI: 10.1111/J.1750-3841.2010.01838.X
Abstract: Freeze-dried commercial Lactobacillus rhamnosus GG (LGG) were encapsulated in an emulsion-based formulation stabilized by whey protein and resistant starch and either spray-dried or freeze-dried to produce probiotic microcapsules. There was no difference in loss of probiotics viability after spray drying or freeze drying. Particle size, morphology, moisture sorption, and water mobility of the powder microcapsules were examined. Particle size analysis and scanning electron microscopy showed that spray-dried LGG microcapsules (SDMC) were small spherical particles, whereas freeze-dried LGG microcapsules (FDMC) were larger nonspherical particles. Moisture sorption isotherms obtained using dynamic vapor sorption showed a slightly higher water uptake in spray-dried microcapsules. The effect of water mobility, as measured by nuclear magnetic resonance (NMR) spectroscopy, at various water activities (a(w) 0.32, 0.57, and 0.70) and probiotic viability during storage at 25 °C was also examined. Increasing the relative humidity of the environment at which the s les were stored caused an increase in water mobility and the rate of loss in viability. The viability data during storage indicated that SDMC had better storage stability compared to FDMC. Although more water was adsorbed for spray-dried than freeze-dried microcapsules, water mobility was similar for corresponding storage conditions because there was a stronger water-binding energy for spray-dried microcapsule. This possibly accounted for the improved survival of probiotics in spray-dried microcapsules.
Publisher: Springer Science and Business Media LLC
Date: 20-11-2010
Publisher: Cambridge University Press (CUP)
Date: 02-2012
Abstract: Familial hemiplegic migraine (FHM) is a rare autosomal dominant subtype of migraine with aura. It is ided into three subtypes FHM1, FHM2 and FHM3, which are caused by mutations in the CACNA1A, ATP1A2 and SCN1A genes respectively. As part of a regular diagnostic service, we investigated 168 patients with FHM symptoms. S les were tested for mutations contained within the CACNA1A gene. Some tested s les (4.43%) showed an FHM1 mutation, with five of the mutations found in exon 5, one mutation in exon 16 and one in exon 17. Four polymorphisms were also detected, one of which occurred in a large percentage of s les (14.88%). The exon 16 2094G A polymorphism, however, has been found to occur in healthy Caucasian control populations up to a frequency of 16% and is not considered to be significantly associated with FHM. A finding of significance, found in a single patient, was the detection of a novel mutation in exon 5 that results in a P225H change. The affected in idual was an 8-year-old female. The exact phenotypic effect of this mutation is unknown, and further studies are needed to understand the pathophysiology of this mutation in FHM1. New information will allow for diagnostic procedures to be constantly updated, thus improving accuracy of diagnosis. It is possible that new information will also aid the development of new therapeutic agents for the treatment of FHM.
Publisher: Elsevier BV
Date: 2013
Publisher: No publisher found
Date: 2010
Publisher: American Chemical Society (ACS)
Date: 16-09-2011
DOI: 10.1021/JF202358M
Abstract: The antioxidants, sodium ascorbate and tocopherol, have contrasting effects on the viability of microencapsulated Lactobacillus rhamnosus GG (LGG) spray-dried powders during storage (4 and 25 °C 32, 57, and 70% relative humidity). The addition of tocopherol improved probiotic viability during storage, while the incorporation of Na-ascorbate alone or in combination with tocopherol had detrimental effects on probiotic survival. The beneficial effect of tocopherol is a consequence of its chemical antioxidative action. The reduced viability in Na-ascorbate containing microcapsule formulations is hypothesized to be due primarily to the production of acetic acids arising from chemical degradation reactions and the catabolism of ascorbate by LGG. This study highlights the importance of considering the detrimental consequences of degradative chemical reactions and the metabolic fate of additives on the viability of probiotics when designing probiotic encapsulant formulations.
Publisher: American Chemical Society (ACS)
Date: 10-11-2010
DOI: 10.1021/JF103484Z
Abstract: Chitosan-glucose conjugates were prepared using Maillard reaction chemistry. Water-soluble and acid-soluble chitosan-glucose mixtures were heated at pH 4.9 and 6.0 at 98 °C. Mixtures at pH 6.0 containing acid-soluble chitosan gelled when heating was continued after reaching 98 °C and withstood gelation for only 30 min at pH 4.9. In contrast, mixtures containing water-soluble chitosan could be heated without gelation at pH 6.0 and 4.9. Examination of the extent of Maillard reaction and antioxidant properties showed that acid-soluble chitosan reacted for 30 min at pH 4.9 had the highest extent of reaction as judged by increased absorbance, the highest degree of modification to the amino group as evidenced by Fourier transform infrared and shifts of the endotherms by differential scanning calorimetry, and the highest antioxidant activity as indicated by ferric reducing power and oxygen radical absorbance capacity. There were significant correlations (p < 0.05) between indices of browning and antioxidant activity.
Location: Australia
No related grants have been discovered for Rangika Weerakkody.